United StatesSILINTAN 25/pills, packaged in a 25-count bottle and manufactured by Shanghai Chinese Medical Works (Shanghai, China) and distributed by ANTHONY TRINH, 123Herbals LLC, is being recalled in the United States; all lots within expiry are included. The FDA found undeclared meloxicam and determined the product is marketed without an approved NDA/ANDA.
What's being recalled
SILINTAN 25/pills, packaged in a 25-count bottle, Shanghai Chinese Medical Works, Shanghai, China
Recalling firm: ANTHONY TRINH, 123Herbals LLC, Rosemead, CA, United States.
How to identify it
All lots within expiry
The hazard
Marketed Without an Approved NDA/ANDA: FDA analysis revealed the presence of undeclared meloxicam.
What to do
Don't stop taking a prescribed medicine without talking to your doctor or pharmacist first. For other products, stop using them and ask the pharmacist, seller or maker what to do.
The notice doesn't give instructions for consumers, so this is general advice for health & beauty recalls. Check the official notice for the details.
Where it was sold
USA nationwide
The official notice
This page is a summary of the notice published by U.S. Food and Drug Administration (enforcement reports), collected from U.S. Food and Drug Administration (enforcement reports). Check the original before you act on it.
Read the official notice (opens in a new tab)